Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Nephrology

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000351758PMID 23941724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk

  2014cited by this paper
• High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.

  2013cited by this paper
• Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism

  2012cited by this paper
• Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity.

  2012cited by this paper
• Serum blood urea nitrogen and plasma brain natriuretic Peptide and low diastolic blood pressure predict cardiovascular morbidity and mortality following discharge in acute decompensated heart failure patients.

  2012cited by this paper
• Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

  2011cited by this paper
• Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins.

  2011cited by this paper
• Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.

  2011cited by this paper
• Chronic renal failure alters endothelial function in cerebral circulation in mice.

  2011cited by this paper
• A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.

  2011cited by this paper
• Chronic inflammation links cardiovascular, metabolic and renal diseases.

  2011cited by this paper
• Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation.

  2011cited by this paper
• New Insight Into the Redox Properties of Uremic Solute Indoxyl Sulfate as a Pro‐ and Anti‐Oxidant

  2011cited by this paper
• Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-ĸB Activation

  2010cited by this paper
• Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

  2010cited by this paper
• Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia

  2010cited by this paper
• Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats.

  2010cited by this paper
• Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

  2010cited by this paper
• Emerging role of the bufadienolides in cardiovascular and kidney diseases.

  2010cited by this paper
• Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

  2010cited by this paper
• Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy.

  2010cited by this paper
• Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure.

  2010cited by this paper
• Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.

  2010cited by this paper
• Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway.

  2010cited by this paper
• Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin*

  2010cited by this paper
• p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

  2010cited by this paper
• National Health and Nutrition Examination Survey

  2010cited by this paper
• Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.

  2010cited by this paper
• Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress.

  2009cited by this paper
• The uremic retention solute p-cresyl sulfate and markers of endothelial damage.

  2009cited by this paper
• Mechanisms of Aortic and Cardiac Dysfunction in Uremic Mice With Aortic Calcification

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

  2009cited by this paper
• Uremic toxins originating from colonic microbial metabolism.

  2009cited by this paper
• Cardiovascular risk and management in chronic kidney disease

  2009cited by this paper
• Indoxyl Sulfate Inhibits Nitric Oxide Production and Cell Viability by Inducing Oxidative Stress in Vascular Endothelial Cells

  2009cited by this paper
• The importance of residual renal function in chronic dialysed patients

  2009cited by this paper
• A bench to bedside view of uremic toxins.

  2008cited by this paper
• What is new in uremic toxicity?

  2008cited by this paper
• Free p-cresol is associated with cardiovascular disease in hemodialysis patients.

  2008cited by this paper
• Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats.

  2008cited by this paper
• Factors associated with mortality in patients new to haemodialysis.

  2007cited by this paper
• Chronic Kidney Disease: Effects on the Cardiovascular System

  2007cited by this paper
• Phenylacetic Acid and Arterial Vascular Properties in Patients with Chronic Kidney Disease Stage 5 on Hemodialysis Therapy

  2007cited by this paper
• An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure

  2007cited by this paper
• Indoxyl Sulfate and Atherosclerotic Risk Factors in Hemodialysis Patients

  2007cited by this paper
• Uremic Cardiomyopathy—An Endogenous Digitalis Intoxication?: Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy. Hypertension 47: 488–495, 2006

  2006cited by this paper
• Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.

  2006cited by this paper
• Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

  2006cited by this paper
• Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy

  2006cited by this paper
• The future of hemodialysis membranes.

  2006cited by this paper
• Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.

  2006cited by this paper
• Elevation of circulating endothelial microparticles in patients with chronic renal failure

  2006cited by this paper
• Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia

  2004cited by this paper
• Oxalic acid alters intracellular calcium in endothelial cells.

  2004cited by this paper
• Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

  2004cited by this paper
• Oral Adsorbent AST-120 Decreases Carotid Intima-Media Thickness and Arterial Stiffness in Patients with Chronic Renal Failure

  2004cited by this paper
• Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.

  2004cited by this paper
• Pathophysiology of Vascular Calcification in Chronic Kidney Disease

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Review on uremic toxins: classification, concentration, and interindividual variability.

  2003cited by this paper
• Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation

  2002cited by this paper
• Uremic toxins and peritoneal dialysis.

  2001cited by this paper
• Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

  2001cited by this paper
• Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study

  2000cited by this paper
• Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992

  2000cited by this paper
• The removal of uremic toxins.

  2000cited by this paper
• Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

  2000cited by this paper
• Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.

  2000cited by this paper
• Serum uric acid and cardiovascular events in successfully treated hypertensive patients.

  1999cited by this paper
• Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.

  1990cited by this paper
• Haemostatic Changes during Dialysis Associated with Thrombus Formation on Dialysis Membranes

  1972cited by this paper

• Research Progress on the Regulatory Effect of Dietary Fiber on Patients with Cardiovascular-Kidney-Metabolic Syndrome

  2026cites this paper
• Association Between Caffeine Intake and Mortality Among Patients with Chronic Kidney Disease: A Population-Based Study

  2026cites this paper
• Association between Neutrophil-to-Lymphocyte ratio and left ventricular hypertrophy in chronic kidney disease patients: a cross-sectional study

  2025cites this paper
• Uremic Serum Exposure Leads to Differential Phenotypic Switch in Porcine Arterial and Venous Smooth Muscle Cells.

  2025cites this paper
• Early Administration of N-Acetylcysteine Provides Renal and Cardiac Mitochondrial and Redox Protection, Preventing the Development of Cardio-Renal Syndrome Type IV Induced by 5/6NX

  2025cites this paper
• Exploring the Interplay Between Kidney Dysfunction and Cardiovascular Disease

  2025cites this paper
• Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.

  2025cites this paper
• Association of chronic kidney disease and cardiovascular disease risk with all-cause mortality: an interaction, joint and mediation analysis in Chinese adults

  2025cites this paper
• Mitochondrial quality control and stress signaling pathways in the pathophysiology of cardio-renal diseases.

  2025cites this paper
• Gene Expression Profile of Cultured Human Coronary Arterial Endothelial Cells Exposed to Serum from Chronic Kidney Disease Patients: Role of MAPK Signaling Pathway

  2025cites this paper
• Targeting Inflammatory Imbalance in Chronic Kidney Disease: Focus on Anti-Inflammatory and Resolution Mediators

  2025cites this paper
• Clinical management of peripheral arterial disease in chronic kidney disease—a comprehensive review from the European Renal Association CKD-MBD Working Group

  2025cites this paper
• Activation of the Na/K-ATPase oxidant amplification loop by uremic toxins drives adipocyte dysfunction in vitro.

  2025cites this paper
• Circulatory endostatin level and risk of cardiovascular events in patients with end-stage renal disease on hemodialysis

  2024cites this paper
• Association between the age-adjusted Charlson Comorbidity Index and complications after kidney transplantation: a retrospective observational cohort study

  2024cites this paper
• Intravascular Imaging-Guided Percutaneous Coronary Intervention in Patients With End-Stage Renal Disease on Maintenance Dialysis

  2024cites this paper
• Chest X-ray Findings and Prognostic Factors in Survival Analysis in Peritoneal Dialysis and Hemodialysis Patients: A Retrospective Cross-Sectional Study

  2024cites this paper
• Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model.

  2024cites this paper
• Accelerated idioventricular rhythm as a manifestation of chronic renocardiac syndrome: A case report

  2024influential citation
• Adequacy of Dialysis and Incidence of Atrial Fibrillation in Patients Undergoing Hemodialysis

  2024cites this paper
• Acute Kidney Injury and Subsequent Cardiovascular Disease: Epidemiology, Pathophysiology, and Treatment.

  2024cites this paper
• Renoprotective mechanisms of exercise training against acute and chronic renal diseases - A perspective based on experimental studies.

  2024cites this paper
• Relationship between dietary fiber and all-cause mortality, cardiovascular mortality, and cardiovascular disease in patients with chronic kidney disease: a systematic review and meta-analysis

  2024cites this paper
• Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4

  2023cites this paper
• Pathophysiological concepts and screening of cardiovascular disease in dialysis patients

  2023cites this paper
• The Characterization of Hemodialysis Membranes in Miniaturized Dialyzers

  2023cites this paper
• Effect of Low Protein Diet Supplemented with Ketoanalogs on Endothelial Function and Protein-Bound Uremic Toxins in Patients with Chronic Kidney Disease

  2023cites this paper
• Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology

  2023cites this paper
• Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility

  2023cites this paper
• Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice

  2023cites this paper
• Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation

  2023cites this paper
• Investigation on the Association of Cardiovascular Markers with Severity of Chronic Pyelonephritis.

  2022cites this paper
• The effects of curcumin-containing supplementations on inflammatory markers and lipid profiles in patients with chronic kidney diseases: a systematic review and meta-analysis of randomized controlled trials

  2022cites this paper
• Consumers' perspectives and experiences of prebiotics and probiotics for gut health in chronic kidney disease.

  2022cites this paper
• Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

  2022cites this paper
• Association of Permanent Vascular Access Dysfunction with Subsequent Risk of Cardiovascular Disease: A Population-Based Cohort Study

  2022cites this paper
• Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations

  2022cites this paper
• Reply to Letter to the Editor: “Improvement of Left Ventricular Function After Renal Transplantation Is Related with Multiple Parameters”

  2022cites this paper
• Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.

  2022cites this paper
• Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid Regurgitation

  2022cites this paper
• Systematic review to compare the outcomes associated with the modalities of expanded hemodialysis (HDx) versus high‐flux hemodialysis and/or hemodiafiltration (HDF) in patients with end‐stage kidney disease (ESKD)

  2022cites this paper
• ASSOCIATION BETWEEN NUTRITIONAL STATUS, VITAMIN D AND INFLAMMATION ON VASCULAR CALCIFICATION IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS

  2022cites this paper
• Therapeutic potential of cranberry for kidney health and diseases

  2022cites this paper
• Aryl hydrocarbon receptor (AhR) reveals evidence of antagonistic pleiotropy in the regulation of the aging process

  2022cites this paper
• Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial

  2021cites this paper
• The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model

  2021cites this paper
• On-line hemodiafiltration modulates atherosclerosis signaling in peripheral lymphomonocytes of hemodialysis patients

  2021cites this paper
• A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week.

  2021cites this paper
• Are Nutraceuticals Beneficial in Chronic Kidney Disease?

  2021cites this paper
• The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients

  2021cites this paper
• Multitargeted interventions to reduce dialysis-induced systemic stress

  2021cites this paper
• Clinical relevance of abstruse transport phenomena in haemodialysis

  2021cites this paper
• Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial

  2021cites this paper
• Pyroptosis: A Common Feature of Immune Cells of Haemodialysis Patients

  2021cites this paper
• Variety of Cardiac Events in Hospitalized Chronic Kidney Disease Patients

  2021cites this paper
• Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease.

  2021cites this paper
• Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication

  2021cites this paper
• Hemocompatible MOF-decorated Pollen Hemoperfusion Absorbent for Rapid and Highly Efficient Removal of Protein-bound Uremic Toxins

  2021cites this paper
• Chronic kidney disease measures for cardiovascular risk prediction.

  2021cites this paper
• Early inflammatory changes and CC chemokine ligand‐8 upregulation in the heart contribute to uremic cardiomyopathy

  2021cites this paper
• Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.

  2021cites this paper
• Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice.

  2021cites this paper
• Delirium accompanies kidney dysfunction in hospitalized elderly patients

  2020cites this paper
• P-Cresylsulfate, the Protein-Bound Uremic Toxin, Increased Endothelial Permeability Partly Mediated by Src-Induced Phosphorylation of VE-Cadherin

  2020influential citation
• Uremic toxin indoxyl sulfate suppresses myocardial Cx43 assembly and expression via JNK activation.

  2020cites this paper
• End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression

  2020cites this paper
• Increasing the Magnesium Concentration in Various Dialysate Solutions Differentially Modulates Oxidative Stress in a Human Monocyte Cell Line

  2020cites this paper
• Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease

  2020cites this paper
• Insight into the Pro-inflammatory and Pro-Fibrotic Role of Macrophage in Heart Failure with Preserved Ejection Fraction.

  2020cites this paper
• Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro.

  2020cites this paper
• Effects of Probiotics on Malnutrition and Health-Related Quality of Life in Patients Undergoing Peritoneal Dialysis: A Randomized Controlled Trial.

  2020cites this paper
• Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis

  2020cites this paper
• Improved cardiovascular autonomic function and decreased protein-bound uremic toxins in patients with end-stage renal disease after peritoneal dialysis

  2020cites this paper
• Adverse Impact of Desulfovibrio spp. and Beneficial Role of Anaerostipes spp. on Renal Function: Insights from a Mendelian Randomization Analysis

  2020cites this paper
• Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis

  2020cites this paper
• IκB Kinase Inhibitor VII Modulates Sepsis-Induced Excessive Inflammation and Cardiac Dysfunction in 5/6 Nephrectomized Mice

  2020influential citation
• Impact of chronic kidney disease on in‐hospital outcomes and readmission rate after edge‐to‐edge transcatheter mitral valve repair

  2020cites this paper
• AgeR deletion decreases soluble fms-like tyrosine kinase 1 production and improves post-ischemic angiogenesis in uremic mice

  2020cites this paper
• The Effects of Chronic Dialysis on Physical Status, Quality of Life, and Arterial Stiffness: A Longitudinal Study in Prevalent Dialysis Patients

  2020cites this paper
• Hydrogen sulfide inhibits aortic valve calcification in heart via regulating RUNX2 by NF-κB, a link between inflammation and mineralization

  2020cites this paper
• Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases

  2020cites this paper
• Clinical assessment of synbiotics for treating chronic kidney disease

  2020cites this paper
• AgeR deletion decreases soluble fms-like tyrosine kinase 1 production and improves post-ischemic angiogenesis in uremic mice

  2020cites this paper
• Prebiotic, probiotic and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis Objective Gut dysbiosis has been implicated in the pathogenesis of chronic kidney disease (CKD)

  2020cites this paper
• A protocol for systematic review and meta-analysis

  2020cites this paper
• Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis.

  2019cites this paper
• Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets

  2019cites this paper
• Hepato‐splanchnic circulatory stress: An important effect of hemodialysis

  2019cites this paper
• Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.

  2019cites this paper
• Cardiovascular complications in hemodialysis patients: current approaches to prolong and improve quality of patients’ life

  2019cites this paper
• Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies

  2019cites this paper
• Unique aspects of peripheral artery disease in patients with chronic kidney disease

  2019cites this paper
• Association between fibre intake and indoxyl sulphate/P-cresyl sulphate in patients with chronic kidney disease: Meta-analysis and systematic review of experimental studies.

  2019cites this paper
• Potential Role of H-Ferritin in Mitigating Valvular Mineralization

  2019cites this paper
• Effect of hemoperfusion with hexadecyl-immobilized cellulose beads on myocardial fatty acid imaging in hemodialysis patients: a case series study

  2019cites this paper
• Effect of Progression in Malnutrition and Inflammatory Conditions on Adverse Events and Mortality in Patients on Maintenance Hemodialysis

  2019cites this paper
• Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?

  2019cites this paper
• “Enteric Dialysis®” – From Concept to Reality [In conjunction with standard care of therapy]

  2018cites this paper
• The role of prognostic assessment with biomarkers in chronic kidney disease: a narrative review

  2018cites this paper
• Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells

  2018cites this paper